Afficher la notice abrégée

dc.contributor.authorCuevas Toro, Ana María
dc.contributor.authorDíaz Batanero, Carmen
dc.contributor.authorSánchez Fuentes, María del Mar 
dc.date.accessioned2025-09-02T11:26:43Z
dc.date.available2025-09-02T11:26:43Z
dc.date.issued2025-05-28
dc.identifier.citationCuevas-Toro, A. M., Díaz-Batanero, C., & Sánchez-Fuentes, M. M. (2025). Sexual desire in women with fibromyalgia: beyond the pain?. The Journal of Sexual Medicine, 22(7), 1106–1114. https://doi.org/10.1093/jsxmed/qdaf123es_ES
dc.identifier.urihttps://hdl.handle.net/10481/106009
dc.description.abstractBackground: Women with fibromyalgia often experience sexual dysfunction, particularly reduced sexual desire, but few studies have used specific measures, such as the Sexual Desire Inventory, to assess this, and the predictors of sexual desire in these women remain unclear. Aim: This study aimed to analyze sexual desire in Spanish women diagnosed with fibromyalgia (fibromyalgia group, FG) and in a control group (CG) of healthy women and to examine the predictors (age, symptoms duration, time since diagnosis, severity of fibromyalgia, antidepressant drugs, depressive symptoms and anxiety symptoms) of sexual desire in the FG. Methods: The sample consisted of 81 women divided into 2 groups FG (n = 46) and CG (n = 35). The average age was 47.23 years (SD = 9.22) for the FG and 46.14 years (SD = 9.52) for the CG. Outcomes: The main outcome measures were sexual desire, as assessed through the Sexual Desire Inventory, severity of fibromyalgia (Fibromyalgia Impact Questionnaire) and anxiety and depression (Hospital Anxiety and Depression Scale). Results: Women in the FG had lower sexual desire than those in the CG. Age, time since diagnosis, and depression were associated with different dimensions of sexual desire. In contrast, fibromyalgia severity, anxiety, and months using SSRIs were not linked to any dimensions of sexual desire. Hierarchical multiple regression analysis revealed that age, time since of FM diagnosis, and depression predicted global sexual desire, accounting for 30% of its variance. Clinical Implications: Assessing sexual desire and addressing depressive symptoms early in women with fibromyalgia is essential for improving their sexual health. Strengths and Limitations: This is the first study to assess different dimensions of sexual desire, including sexual desire for an attractive person, while simultaneously examining key factors associated with sexual desire in women with fibromyalgia. However, the sample size is relatively small, and the study lacks a longitudinal design. Conclusion: Women with FG have lower sexual desire than healthy women, primarily due to age, time since diagnosis, and depressive symptoms.es_ES
dc.description.sponsorshipUniversidad de Granada/CBUAes_ES
dc.language.isoenges_ES
dc.publisherOxford University Presses_ES
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivs 3.0 Licensees_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es_ES
dc.subjectSexual desirees_ES
dc.subjectFibromyalgia es_ES
dc.subjectDepressive symptomses_ES
dc.titleSexual desire in women with fibromyalgia: beyond the pain?es_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1093/jsxmed/qdaf123
dc.type.hasVersionVoRes_ES


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License